Adverse event reporting
Adverse event reporting is the system through which doctors, patients and manufacturers report harm from drugs and medical devices to the FDA. Reports filed before your injury can help show a manufacturer already knew about a risk and failed to act on it.
.avif)
What is adverse event reporting?
Adverse event reporting is the mechanism for collecting information about harm associated with drugs and medical devices after they reach the market.
It exists because clinical trials cannot detect everything. Trials involve limited numbers of people over limited periods, so rare or delayed effects surface only in wider use.
Reports come from healthcare providers, patients and manufacturers, and the FDA maintains databases of them that are publicly accessible.
For injured people the system is also a way to contribute to detection, since patterns emerge only when events are reported.
Why do these reports matter in litigation?
They establish the knowledge element that failure to warn claims depend on.
- They document when reports of a specific harm began appearing
- They show the volume and pattern of similar events over time
- Manufacturer reporting obligations create a record of internal awareness
- They can reveal a gap between what was known and what was disclosed
- They support arguments that action should have been taken sooner
What are the limits of this data?
Reports are not proof of causation. A report records that an event occurred after use, not that the product caused it.
Underreporting is substantial and well recognized, so the reported numbers understate actual incidence, sometimes considerably.
The data quality varies, and courts treat these reports as one input among many rather than as scientific evidence standing alone.
Reports also arrive with varying detail, and many lack the clinical information needed to assess them meaningfully.
How is this evidence developed?
Public databases provide a starting point, and searching them is a routine early step in evaluating a pharmaceutical or device claim.
The more valuable material is internal. A manufacturer's own complaint files, safety reviews and correspondence with regulators are obtained through discovery.
Comparing what appeared internally against what appeared in the labeling frequently establishes the core of a failure to warn claim.
Timing analysis is often the most productive use, establishing what the reporting picture looked like at the moment a warning should have changed.
Common questions
Can I report an adverse event myself?
Yes. Patients can report directly to the FDA, and doing so creates a record independent of any claim you may bring.
Does an adverse event report prove the drug hurt me?
No. It documents an event following use. Causation requires medical evidence specific to your circumstances.
Are these reports public?
The FDA maintains publicly searchable databases, though internal manufacturer records are obtained only through litigation discovery.
Can I see reports about a drug I took?
The FDA maintains publicly searchable databases, so you can review reported events yourself. What is not public is the manufacturer's internal complaint file, which is obtained through litigation discovery and is frequently far more revealing. Reports filed before your injury are the most useful, since they establish what the manufacturer knew and when it should have acted on that knowledge. Underreporting means the published figures understate actual incidence.
Hurt in New Jersey? Let's Talk.
James Vasquez gives injured people across New Jersey a free, no obligation case review. Tell us what happened and we'll walk you through your options and what your claim may be worth.
.png)


.jpg)





























